A large cohort study has found that the risk of being newly diagnosed with atrial fibrillation within a year of a stroke, ...

The National Assembly criticized the Ministry of Health and Welfare after the latter revised the outlay for the second ...

Samsung Bioepis is tightening its grip on the U.S. biosimilar market with FDA approval to sell an unbranded version of ...

Yonsei University College of Medicine and the KAIST Graduate School of Medical Science and Engineering (GSMSE) signed a ...

BeOne Medicines Korea, the newly rebranded Korean subsidiary of global oncology company BeOne Medicines (formerly BeiGene), ...

"Doctor, my hair is suddenly falling out. Didn't you say this anti-cancer drug wouldn't cause hair loss?"Ms. Jang, a ...

TiumBio announced Wednesday that it will present clinical trial results for merigolix (TU2670), a drug in development for the ...

LG H&H’s luxury skincare brand THE WHOO has unveiled a special summer edition of its signature product, the Bichup First Moisture Anti-Aging Essence, in collaboration with Danha, a modern hanbok label ...

Novelty Nobility said Thursday it has voluntarily withdrawn its preliminary listing review application for Kosdaq.In July last year, the company received an A grade from two specialized rating agencie ...

GCCL (Global Clinical Central Lab) said Thursday it established an assay for monoamine oxidase B (MAO-B), a central nervous ...

Vaxcellbio said it secured a new government-funded R&D project worth 8.6 billion won ($6.3 million) under the Ministry of ...

Lixiana’s (edoxaban) patent clock is now ticking loud enough for every generics player in Korea to hear.Last Friday, Korean ...